XPL Xplus S.A.
Xplus S.A. offers IT software solutions in Poland, European Union, and internationally. The company offers XPLUS- Testing, an autonomous regression testing for dynamics 365; XPLUS- User Security Governance, a full audit readiness, license control, and scalable role management for Dynamics 365; XPLUS- Discovery, a full visibility and control over what happens inside Dynamics 365. It also provides compliance and risk reduction solutions, such as auditing and compliance, cost and license optimization, GDPR compliance, anti-fraud, error detection, and monitoring; quality and testing solutions include performance testing, regression testing, automated testing for D365 business central, and testing lite; and operational confidence solutions, such as AI-powered observability, business process mining, performance monitoring, polish localization. The company was founded in 2002 and is based in Warsaw, Poland. Xplus S.A. is a subsidiary of FCBSL Spolka Z Ograniczona Odpowiedzialnoscia.…
Industry Peers
Software - InfrastructureKey Statistics
About Xplus (WSE: XPL)
›
Xplus (WSE: XPL) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Software - Infrastructure industry, part of the Technology sector, and reports about 42 employees.
The shares were at 2.850 PLN on 20 November 2026, down 22.8% over 52 weeks. Its 52-week range is 1.900 PLN to 3.820 PLN: the price is 25.4% below the high and 50.0% above the low.
At a market capitalisation of 198.49M PLN, it trades at 19.0 times trailing earnings. The median trailing P/E of its 14 largest Software - Infrastructure peers is 36.9, a discount of 48% for XPL. It pays a dividend yielding 9.15% (it pays out 176% of its earnings), against a median of 1.14% among the dividend payers in that peer group.
Xplus reports return on equity of 37.4%, an operating margin of 14.1% and revenue up 38.2% year over year.
It holds more cash than debt, a net cash position of 13.82M PLN. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.